Delivery Order SPE2DB22D2009-SPE2DB25FL7ND

Award Date 1/27/25
Potential Completion Date 1/28/25
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The $17,637.58 firm fixed-price contract is for the delivery of Ondansetron HCL 4 mg tablets to support military healthcare programs. The IDC with the DLA, valued at $999,999,999 and running through November 2026, enables efficient government procurement of a comprehensive...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,978.24 firm fixed price delivery order contract is for the supply of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of July 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of Ondansetron ODT 4 mg tablets. The award, valued at $1,896.08, is a delivery order under an Indefinite Delivery Contract (IDC) worth up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a delivery order under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,026.58, is for the delivery of Ondansetron ODT 4 mg tablets to support federal healthcare programs. The IDC with DLA Troop Support Medical, valued at $999,999,999, serves as the primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Ondansetron ODT 4 mg tablets. The $7,500.96 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical. This IDC serves as a comprehensive contracting vehicle for the company to supply a wide range of pharmaceutical products and medical supplies,...
This federal contract award, valued at $12,349.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order (DO) under a larger Indefinite Delivery Contract (IDC) with the DLA, provides for the delivery of Ondansetron ODT 4 mg tablets to support military healthcare programs. The IDC, valued at $999,999,999, serves as a primary vehicle for Amerisourcebergen to...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The $12,528.96 firm fixed price delivery order is for the supply of Ondansetron ODT 4 MG tablets. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Ondansetron ODT 8 mg tablets. The award, made by the Defense Logistics Agency (DLA), is a Delivery Order under an Indefinite Delivery Contract (IDC) with a ceiling value of $4,354.88 and a period of performance through November 1, 2024. The contract is for Firm Fixed Price with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 IDC with...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $9,449.86 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract covers the supply of 4 mg Ondansetron HCL tablets to support military healthcare programs. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 IDC with the DLA Troop Support Medical, as well as a separate...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $9,940.32, is for the delivery of Ondansetron HCL 4 mg tablets. The IDC has a total potential value of $999,999,999 and runs through November 2026, providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB25FL7ND
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,476.87, is for the procurement of Ondansetron ODT 4 mg tablets. The IDC has a total potential value of $999,999,999 and runs through November 2026, providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 4/28/25, 9:43 AM